ACCO BRANDS Corp — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that ACCO BRANDS Corp filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.52B | Mar 9, 2026 |
| FY2025 | Dec 31, 2024 | $1.67B | Mar 9, 2026 |
| FY2025 | Dec 31, 2023 | $1.83B | Mar 9, 2026 |
| FY2024 | Dec 31, 2022 | $1.95B | Feb 21, 2025 |
| FY2023 | Dec 31, 2021 | $2.03B | Feb 23, 2024 |
| FY2020 | Dec 31, 2020 | $460.10M | Apr 12, 2021 |
| FY2020 | Sep 30, 2020 | $444.10M | Apr 12, 2021 |
| FY2020 | Jun 30, 2020 | $366.90M | Apr 12, 2021 |
| FY2020 | Mar 31, 2020 | $384.10M | Apr 12, 2021 |
| FY2020 | Dec 31, 2019 | $537.40M | Apr 12, 2021 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.52B | Mar 9, 2026 |
| FY2025 | Dec 31, 2024 | $1.67B | Mar 9, 2026 |
| FY2025 | Dec 31, 2023 | $1.83B | Mar 9, 2026 |
| FY2024 | Dec 31, 2022 | $1.95B | Feb 21, 2025 |
| FY2023 | Dec 31, 2021 | $2.03B | Feb 23, 2024 |
| FY2022 | Dec 31, 2020 | $1.66B | Feb 24, 2023 |
| FY2021 | Dec 31, 2019 | $1.96B | Feb 23, 2022 |
| FY2020 | Dec 31, 2018 | $1.94B | Apr 12, 2021 |
| FY2019 | Dec 31, 2017 | $1.95B | Feb 27, 2020 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $566.80M | Feb 28, 2018 |
| FY2017 | Sep 30, 2017 | $532.20M | Feb 28, 2018 |
| FY2017 | Jun 30, 2017 | $490.00M | Feb 28, 2018 |
| FY2017 | Mar 31, 2017 | $359.80M | Feb 28, 2018 |
| FY2017 | Dec 31, 2016 | $437.60M | Feb 28, 2018 |
| FY2017 | Sep 30, 2016 | $431.30M | Feb 28, 2018 |
| FY2017 | Jun 30, 2016 | $410.10M | Feb 28, 2018 |
| FY2017 | Mar 31, 2016 | $278.10M | Feb 28, 2018 |
| FY2016 | Dec 31, 2015 | $412.10M | Feb 27, 2017 |
| FY2016 | Sep 30, 2015 | $413.60M | Feb 27, 2017 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $500.00M | Mar 9, 2026 |
| FY2025 | Dec 31, 2024 | $555.40M | Mar 9, 2026 |
| FY2025 | Dec 31, 2023 | $598.30M | Mar 9, 2026 |
| FY2024 | Dec 31, 2022 | $552.30M | Feb 21, 2025 |
| FY2023 | Dec 31, 2021 | $614.90M | Feb 23, 2024 |
| FY2020 | Dec 31, 2020 | $143.10M | Apr 12, 2021 |
| FY2020 | Sep 30, 2020 | $127.10M | Apr 12, 2021 |
| FY2020 | Jun 30, 2020 | $110.00M | Apr 12, 2021 |
| FY2020 | Mar 31, 2020 | $112.20M | Apr 12, 2021 |
| FY2020 | Dec 31, 2019 | $186.00M | Apr 12, 2021 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $41.30M | Mar 9, 2026 |
| FY2025 | Dec 31, 2024 | ($101.60M) | Mar 9, 2026 |
| FY2025 | Dec 31, 2023 | ($21.80M) | Mar 9, 2026 |
| FY2024 | Dec 31, 2022 | ($13.20M) | Feb 21, 2025 |
| FY2023 | Dec 31, 2021 | $101.90M | Feb 23, 2024 |
| FY2020 | Dec 31, 2020 | $29.80M | Apr 12, 2021 |
| FY2020 | Sep 30, 2020 | $18.80M | Apr 12, 2021 |
| FY2020 | Jun 30, 2020 | $5.40M | Apr 12, 2021 |
| FY2020 | Mar 31, 2020 | $8.00M | Apr 12, 2021 |
| FY2020 | Dec 31, 2019 | $43.50M | Apr 12, 2021 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $92.30M | Mar 9, 2026 |
| FY2025 | Dec 31, 2024 | ($37.00M) | Mar 9, 2026 |
| FY2025 | Dec 31, 2023 | $44.70M | Mar 9, 2026 |
| FY2024 | Dec 31, 2022 | $34.80M | Feb 21, 2025 |
| FY2023 | Dec 31, 2021 | $151.00M | Feb 23, 2024 |
| FY2020 | Dec 31, 2020 | $42.20M | Apr 12, 2021 |
| FY2020 | Sep 30, 2020 | $34.30M | Apr 12, 2021 |
| FY2020 | Jun 30, 2020 | $18.50M | Apr 12, 2021 |
| FY2020 | Mar 31, 2020 | $17.40M | Apr 12, 2021 |
| FY2020 | Dec 31, 2019 | $68.10M | Apr 12, 2021 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $22.00M | Mar 9, 2026 |
| FY2025 | Dec 31, 2024 | $23.00M | Mar 9, 2026 |
| FY2025 | Dec 31, 2023 | $25.80M | Mar 9, 2026 |
| FY2024 | Dec 31, 2022 | $26.30M | Feb 21, 2025 |
| FY2023 | Dec 31, 2021 | $26.60M | Feb 23, 2024 |
| FY2022 | Dec 31, 2020 | $19.70M | Feb 24, 2023 |
| FY2021 | Dec 31, 2019 | $21.80M | Feb 23, 2022 |
| FY2020 | Dec 31, 2018 | $23.80M | Apr 12, 2021 |
| FY2019 | Dec 31, 2017 | $23.50M | Feb 27, 2020 |
| FY2018 | Dec 31, 2016 | $21.00M | Feb 27, 2019 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $346.70M | Mar 9, 2026 |
| FY2025 | Dec 31, 2024 | $365.70M | Mar 9, 2026 |
| FY2025 | Dec 31, 2023 | $393.50M | Mar 9, 2026 |
| FY2024 | Dec 31, 2022 | $376.70M | Feb 21, 2025 |
| FY2023 | Dec 31, 2021 | $392.60M | Feb 23, 2024 |
| FY2022 | Dec 31, 2020 | $336.30M | Feb 24, 2023 |
| FY2021 | Dec 31, 2019 | $389.90M | Feb 23, 2022 |
| FY2020 | Dec 31, 2018 | $392.40M | Apr 12, 2021 |
| FY2019 | Dec 31, 2017 | $415.50M | Feb 27, 2020 |
| FY2018 | Dec 31, 2016 | $328.80M | Feb 27, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $68.70M | Mar 9, 2026 |
| FY2025 | Dec 31, 2024 | $148.20M | Mar 9, 2026 |
| FY2025 | Dec 31, 2023 | $128.70M | Mar 9, 2026 |
| FY2024 | Dec 31, 2022 | $77.60M | Feb 21, 2025 |
| FY2023 | Dec 31, 2021 | $159.60M | Feb 23, 2024 |
| FY2022 | Dec 31, 2020 | $119.20M | Feb 24, 2023 |
| FY2021 | Dec 31, 2019 | $203.90M | Feb 23, 2022 |
| FY2020 | Dec 31, 2018 | $194.80M | Apr 12, 2021 |
| FY2019 | Dec 31, 2017 | $204.90M | Feb 27, 2020 |
| FY2018 | Dec 31, 2016 | $167.10M | Feb 27, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | $17.70M | Feb 24, 2023 |
| FY2022 | Dec 31, 2021 | $21.20M | Feb 24, 2023 |
| FY2022 | Dec 31, 2020 | $15.30M | Feb 24, 2023 |
| FY2021 | Dec 31, 2019 | $32.80M | Feb 23, 2022 |
| FY2020 | Dec 31, 2018 | $34.10M | Apr 12, 2021 |
| FY2019 | Dec 31, 2017 | $31.00M | Feb 27, 2020 |
| FY2018 | Dec 31, 2016 | $18.50M | Feb 27, 2019 |
| FY2017 | Dec 31, 2015 | $27.60M | Feb 28, 2018 |
| FY2016 | Dec 31, 2014 | $29.60M | Feb 27, 2017 |
| FY2015 | Dec 31, 2013 | $36.60M | Feb 24, 2016 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.25B | Mar 9, 2026 |
| FY2025 | Dec 31, 2024 | $2.23B | Mar 9, 2026 |
| FY2024 | Dec 31, 2023 | $2.64B | Feb 21, 2025 |
| FY2023 | Dec 31, 2022 | $2.79B | Feb 23, 2024 |
| FY2022 | Dec 31, 2021 | $3.09B | Feb 24, 2023 |
| FY2021 | Dec 31, 2020 | $3.05B | Feb 23, 2022 |
| FY2020 | Dec 31, 2019 | $2.79B | Apr 12, 2021 |
| FY2019 | Dec 31, 2018 | $2.79B | Feb 27, 2020 |
| FY2018 | Dec 31, 2017 | $2.80B | Feb 27, 2019 |
| FY2017 | Dec 31, 2016 | $2.06B | Feb 28, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.59B | Mar 9, 2026 |
| FY2025 | Dec 31, 2024 | $1.62B | Mar 9, 2026 |
| FY2024 | Dec 31, 2023 | $1.86B | Feb 21, 2025 |
| FY2023 | Dec 31, 2022 | $1.98B | Feb 23, 2024 |
| FY2022 | Dec 31, 2021 | $2.23B | Feb 24, 2023 |
| FY2021 | Dec 31, 2020 | $2.31B | Feb 23, 2022 |
| FY2020 | Dec 31, 2019 | $2.01B | Apr 12, 2021 |
| FY2019 | Dec 31, 2018 | $2.00B | Feb 27, 2020 |
| FY2018 | Dec 31, 2017 | $2.03B | Feb 27, 2019 |
| FY2017 | Dec 31, 2016 | $1.36B | Feb 28, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $664.60M | Mar 9, 2026 |
| FY2025 | Dec 31, 2024 | $606.10M | Mar 9, 2026 |
| FY2025 | Dec 31, 2023 | $787.00M | Mar 9, 2026 |
| FY2025 | Dec 31, 2022 | $810.10M | Mar 9, 2026 |
| FY2024 | Dec 31, 2021 | $864.80M | Feb 21, 2025 |
| FY2023 | Dec 31, 2020 | $742.70M | Feb 23, 2024 |
| FY2022 | Dec 31, 2019 | $773.70M | Feb 24, 2023 |
| FY2021 | Dec 31, 2018 | $789.70M | Feb 23, 2022 |
| FY2020 | Dec 31, 2017 | $774.10M | Apr 12, 2021 |
| FY2019 | Dec 31, 2016 | $708.70M | Feb 27, 2020 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $478.50M | Mar 9, 2026 |
| FY2025 | Dec 31, 2024 | $446.40M | Mar 9, 2026 |
| FY2025 | Dec 31, 2023 | $590.00M | Mar 9, 2026 |
| FY2024 | Dec 31, 2022 | $671.50M | Feb 21, 2025 |
| FY2023 | Dec 31, 2021 | $802.50M | Feb 23, 2024 |
| FY2022 | Dec 31, 2020 | $827.40M | Feb 24, 2023 |
| FY2021 | Dec 31, 2019 | $718.60M | Feb 23, 2022 |
| FY2020 | Dec 31, 2018 | $708.90M | Apr 12, 2021 |
| FY2019 | Dec 31, 2017 | $670.30M | Feb 27, 2020 |
| FY2018 | Dec 31, 2016 | $587.10M | Feb 27, 2019 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($675.30M) | Mar 9, 2026 |
| FY2025 | Dec 31, 2024 | ($687.60M) | Mar 9, 2026 |
| FY2024 | Dec 31, 2023 | ($556.00M) | Feb 21, 2025 |
| FY2023 | Dec 31, 2022 | ($504.40M) | Feb 23, 2024 |
| FY2022 | Dec 31, 2021 | ($462.00M) | Feb 24, 2023 |
| FY2021 | Dec 31, 2020 | ($537.30M) | Feb 23, 2022 |
| FY2020 | Dec 31, 2019 | ($574.20M) | Apr 12, 2021 |
| FY2019 | Jan 1, 2019 | ($656.30M) | Feb 27, 2020 |
| FY2019 | Dec 31, 2018 | ($656.80M) | Feb 27, 2020 |
| FY2018 | Dec 31, 2017 | ($739.20M) | Feb 27, 2019 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2021 | Dec 31, 2021 | $41.20M | Feb 23, 2022 |
| FY2021 | Dec 31, 2020 | $36.60M | Feb 23, 2022 |
| FY2021 | Dec 31, 2019 | $27.80M | Feb 23, 2022 |
| FY2021 | Dec 31, 2018 | $67.00M | Feb 23, 2022 |
| FY2020 | Dec 31, 2017 | $76.90M | Apr 12, 2021 |
| FY2019 | Dec 31, 2016 | $42.90M | Feb 27, 2020 |
| FY2018 | Dec 31, 2015 | $55.40M | Feb 27, 2019 |
| FY2017 | Dec 31, 2014 | $53.20M | Feb 28, 2018 |
| FY2016 | Dec 31, 2013 | $53.50M | Feb 27, 2017 |
| FY2015 | Dec 31, 2012 | $50.00M | Feb 24, 2016 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Mar 9, 2026 |
| FY2025 | Dec 31, 2024 | (1) | Mar 9, 2026 |
| FY2025 | Dec 31, 2023 | 0 | Mar 9, 2026 |
| FY2024 | Dec 31, 2022 | 0 | Feb 21, 2025 |
| FY2023 | Dec 31, 2021 | 1 | Feb 23, 2024 |
| FY2020 | Dec 31, 2020 | 0 | Apr 12, 2021 |
| FY2020 | Sep 30, 2020 | 0 | Apr 12, 2021 |
| FY2020 | Jun 30, 2020 | 0 | Apr 12, 2021 |
| FY2020 | Mar 31, 2020 | 0 | Apr 12, 2021 |
| FY2020 | Dec 31, 2019 | 0 | Apr 12, 2021 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Mar 9, 2026 |
| FY2025 | Dec 31, 2024 | (1) | Mar 9, 2026 |
| FY2025 | Dec 31, 2023 | 0 | Mar 9, 2026 |
| FY2024 | Dec 31, 2022 | 0 | Feb 21, 2025 |
| FY2023 | Dec 31, 2021 | 1 | Feb 23, 2024 |
| FY2020 | Dec 31, 2020 | 0 | Apr 12, 2021 |
| FY2020 | Sep 30, 2020 | 0 | Apr 12, 2021 |
| FY2020 | Jun 30, 2020 | 0 | Apr 12, 2021 |
| FY2020 | Mar 31, 2020 | 0 | Apr 12, 2021 |
| FY2020 | Dec 31, 2019 | 0 | Apr 12, 2021 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 90.14M | Mar 9, 2026 |
| FY2025 | Dec 31, 2024 | 92.88M | Mar 9, 2026 |
| FY2025 | Dec 31, 2023 | 94.90M | Mar 9, 2026 |
| FY2024 | Dec 31, 2022 | 94.30M | Feb 21, 2025 |
| FY2023 | Dec 31, 2021 | 95.80M | Feb 23, 2024 |
| FY2022 | Dec 31, 2020 | 94.90M | Feb 24, 2023 |
| FY2021 | Dec 31, 2019 | 96.40M | Feb 23, 2022 |
| FY2020 | Dec 31, 2018 | 102.70M | Apr 12, 2021 |
| FY2019 | Dec 31, 2017 | 106.70M | Feb 27, 2020 |
| FY2018 | Dec 31, 2016 | 107.91M | Feb 27, 2019 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $27.00M | Mar 9, 2026 |
| FY2025 | Dec 31, 2024 | $28.40M | Mar 9, 2026 |
| FY2025 | Dec 31, 2023 | $28.50M | Mar 9, 2026 |
| FY2024 | Dec 31, 2022 | $28.60M | Feb 21, 2025 |
| FY2023 | Dec 31, 2021 | $25.80M | Feb 23, 2024 |
| FY2022 | Dec 31, 2020 | $24.60M | Feb 24, 2023 |
| FY2021 | Dec 31, 2019 | $24.40M | Feb 23, 2022 |
| FY2020 | Dec 31, 2018 | $25.10M | Apr 12, 2021 |
| FY2019 | Dec 31, 2017 | $0 | Feb 27, 2020 |
| FY2018 | Dec 31, 2016 | $0 | Feb 27, 2019 |